Splenic marginal zone lymphoma: Clinical characteristics and prognostic factors in a series of 60 patients

Blood

Volumn 100, Issue 5, 2002, Pages 1648-1654

  Chacón, Jose I ^a,b   Mollejo, Manuela ^a,b   Muñoz, Enriqueta ^a,b   Algara, Patricia ^a,b   Mateo, Marisol ^a,b   Lopez, Luis ^a,b   Andrade, Jesús ^a,b   Carbonero, Iciar García ^a,b   Martínez, Beatriz ^a,b   Piris, Miguel A ^a,b   Cruz, Miguel A ^a,b  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SPLENECTOMY;

EID: 0036721471     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v100.5.1648.h81702001648_1648_1654     Document Type: Article

References (16)

1. Splenic marginal zone cell lymphoma
2. Splenic lymphoma with villous lymphocytes: Natural history and response to therapy in 50 cases
3. Splenic lymphoma with villous lymphocytes: Clinical presentation, biology and prognostic factors in a series of 100 patients
4. "Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma of marginal zone cell lymphoma
5. Non-malt marginal zone B-cell lymphomas: A description of clinical presentation and outcome on 124 patients
6. Splenic marginal zone lymphoma
7. Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas
8. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma
9. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
10. Cytogenetic studies in splenic lymphoma with villous lymphocytes
11. Splenic lymphoma with villous lymphocytes: Analysis of BCL-1 rearrangements and expression of the cyclin D1 gene
12. Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutations
13. p53 abnormalities in splenic lymphoma with villous lymphocytes
14. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course
15. Splenomegalic immunocytoma with circulating hairy cells: Report of eight cases and review of the literature
16. Fludarabine: An effective treatment in patients with splenic lymphoma with villous lymphocytes